Pharmagen, Inc.
PHRX
$0.00
$0.000.00%
OTC PK
| 03/31/2014 | 12/31/2013 | 09/30/2013 | 06/30/2013 | 03/31/2013 | |
|---|---|---|---|---|---|
| Revenue | 4.41M | 4.81M | 4.78M | 5.49M | 5.50M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.41M | 4.81M | 4.78M | 5.49M | 5.50M |
| Cost of Revenue | 1.66M | 1.76M | 2.18M | 3.32M | 3.42M |
| Gross Profit | 2.75M | 3.05M | 2.60M | 2.18M | 2.09M |
| SG&A Expenses | 4.99M | 5.21M | 4.82M | 4.25M | 4.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.65M | 6.97M | 7.00M | 7.57M | 7.71M |
| Operating Income | -2.24M | -2.16M | -2.22M | -2.08M | -2.20M |
| Income Before Tax | -5.87M | -6.00M | -4.61M | -4.30M | -3.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.87 | -6.00 | -4.61 | -4.30 | -3.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.87M | -6.00M | -4.61M | -4.30M | -3.27M |
| EBIT | -2.24M | -2.16M | -2.22M | -2.08M | -2.20M |
| EBITDA | -2.13M | -2.06M | -2.14M | -2.02M | -2.16M |
| EPS Basic | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.63B | 1.53B | 1.50B | 1.50B | 1.48B |
| Average Diluted Shares Outstanding | 1.63B | 1.53B | 1.50B | 1.50B | 1.48B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |